Objective: Ageing is known to be associated with changes within the heart. We investigated whether the coronary response to endothelin-1 (ET) and sarafotoxin S6c (S6c) is altered with increasing age, before and after cardioplegic arrest. Methods: Using an isolated rat heart model, increasing concentrations of ET and S6c were administered to rats of different ages (group I5one month; group II5five months; group III521 months). An identical series of experiments was performed following the addition of indomethacin and The coronary vasoconstrictor response to ET-1 and S6c increases with age. The increased vasoconstriction in response to ET-1 is independent of the decrease in NO release seen with ageing.
Introduction
whereas the contractile response to a-adrenoceptor stimulation appears to be unaltered [6, 7] . Endothelium-depenAgeing is known to be associated with biochemical and dent relaxation is also reduced with age. We have previousfunctional changes in the heart [1, 2] . These changes can ly demonstrated that the basal and stimulated release of affect one or more of the different cellular components of nitric oxide (NO) by the coronary endothelium decreases the heart, including the coronary endothelium. The endowith age in the rat [8] . thelium constitutes a complex dynamic organ with diverse
Endothelins are a group of recently discovered peptides functions, which include the synthesis and release of [9] . Endothelin-1 (ET-1) is the most potent endogenous vasoactive substances that modulate vascular tone [3] .
vasoconstrictor substance discovered to date. ET levels are The effects of b-adrenoceptor stimulation on vascular elevated in a number of cardiovascular disorders, e.g. smooth muscle responses at different ages have been following myocardial infarction, heart failure and followextensively investigated. The vasodilatation in response to ing cardioplegic arrest and cardiac surgery [10] [11] [12] [13] [14] [15] . The b-adrenoceptor stimulation decreases with age [4, 5] , ageing heart is less tolerant of periods of ischaemia. Ischaemia and reperfusion result in a reduction in coronary flow (so called 'low coronary reflow') [16] . It has been CaCl 2.25 and glucose 11.0, which was continuously 2 suggested that elevated levels of ET may be responsible, at gassed with 95% O and 5% CO , and maintained at 378C. 2 2 least in part, for the low coronary reflow phenomenon [17] . The Krebs buffer flowed from a reservoir that was 100 cm One possible mechanism for this may be due to increased above the heart. The heart was suspended in a water sensitivity to ET.
jacketed chamber maintained at 378C. There have been a number of previous studies examinCoronary flow was monitored by an in-line electroing whether the response to ET alters with age. Some magnetic flow probe (ECM2 20 ml, Scalar, Delft, Netherstudies have shown a reduced response to ET-1 with age in lands) connected to its compatible flowmeter (MDL 1401, the rat aorta, mesenteric and renal arteries [18] [19] [20] . Scalar). This provided an accurate (0.0-40.0 ml / min) However, it has also been reported that ET-1 has no effect digital read-out of mean coronary flow, with a simultawith ageing in rat aorta [21] . It appears that there is neous hard copy recording through a connection with a considerable heterogeneity in response to ET in different chart recorder (RS3400, Gould Electronics, Hainault, UK). vascular beds. In view of the important role that ET This allowed accurate monitoring of steady-state conappears to play in the regulation of vascular tone, it is ditions (less than 0.1 ml / min change in coronary flow over important to establish whether the coronary response to ET 3 min). Heart rate was measured using a pressure transalters with ageing.
ducer within the aortic flow-line, attached to the same chart The effect of age on the contractile response of intact recorder. The resultant waveform was analysed by an coronary arteries to ET has not been investigated previousin-built module (Gould) that allowed continuous recording ly. The aim of this study was to investigate if the response of heart rate. of rat coronary arteries to ET-1 and sarafotoxin S6c (ET In the experiments looking at the effects of ET-1 B agonist) is altered with increasing age. In addition, the following ischaemia, a model of cardioplegic arrest, response to ET-1 following prolonged cardioplegic arrest, mimicking the conditions of the donor heart undergoing in a model mimicking the conditions experienced during cardiac transplantation, was used. This was achieved by cardiac transplantation, was studied in rats of different infusing 10 ml of St Thomas' Hospital No. 1 Solution ages.
(made up in 1 l Ringer's lactate solution) at 48C via the side-arm of the aortic cannula from a reservoir that was 60 cm above the heart. The heart was then maintained 2. Methods immersed in cardioplegic solution at 48C for 4 h.
Animals

Drugs and chemicals
Male Sprague-Dawley rats were used in all experiments. The drugs used in this experiment were all made up to The age groups studied were as follows: Group I, one the required concentration in the Krebs buffer. The drugs month (6one week); group II, four-five months and used were endothelin-1 (Peninsula Labs, Merseyside, UK) Group III, 21 months (6two months). In all studies, (initially dissolved in 0.1% ethanol and then further diluted animals received humane care in compliance with the to the correct concentration in Krebs) and sarafotoxin S6c 'Principles of Laboratory Animal Care' formulated by the (Peninsula Labs). In some of the experiments (see exNational Society for Medical Research and the 'Guide for The Langendorff isolated rat heart preparation was used in this study, as has already been described in detail 2.4. Experimental time course elsewhere [17, 22] . Briefly, the animals were sacrificed by cervical dislocation. The femoral vein was immediately 2.4.1. Effect of endothelin-1 on coronary flow at different exposed and heparin (200 IU) was injected. The heart was ages then excised and immediately placed in ice-cold (48C)
Each heart was perfused in the Langendorff mode with Krebs solution. with increasing doses of ET-1 (10 to 10 M) in the used to compare between groups. Significance was assame manner as for the experiments performed preissumed when the P value was less than 0.05. Values are chaemia. Coronary flow was recorded at each time point.
given as mean6standard error of the mean (SEM).
Comparison of effects of endothelin-1 pre-vs.
Results post cardioplegic arrest
Due to the detrimental effects of high doses of ET-1 on The baseline characteristics and coronary flows for each coronary flow, it was not possible to compare the effects of experimental group are shown in Table 1 . ET-1 pre-and post ischaemia in the same hearts. In order to compare the effects, the results of the two previous experiments were compared.
3.1. Effect of endothelin-1 on coronary flow at different ages ( Fig. 1) 
Comparison of the effects of endothelin-1 with
As expected, there was a dose-dependent decrease in and without inhibition of endogenous vasodilator release coronary flow in response to increasing doses of ET-1. At In this series of experiments, we studied the effects of each of the concentrations studied, the vasoconstriction ET-1 on coronary flow during the inhibition of NO and seen was greater in the older groups of rats (groups II and prostacyclin release. Hearts were perfused throughout the III) when compared to the young rats (group I). The effect 24 experiment with Krebs to which 10 M L-NAME and of ET-1 on heart rate is shown in Table 2 . In all three age fused with increasing doses of ET-1 (10 to 10 M) in dys-rhythmic due to ischaemia, with a resultant significant the same manner as for the experiments performed above. reduction in heart rate. (Fig. 2) L-NAME and indomethacin (Fig. 4) n CF n CF n CF (ml / min) CF (ml / min) n CF (ml / min) (ml / min) (ml / min) pre-ischaemia post-ischaemia 
Effect of endothelin-1 on coronary flow at different
greater decrease in coronary flow following ischaemia at ages following cardioplegic arrest (Fig. 2) all the doses of ET-1 studied, which was highly significant. A similar trend was seen in the group II and III animals, In a similar manner to pre-ischaemia, there was a dosehowever, this only reached statistical significance at con-29 dependent decrease in coronary flow in response to ET-1. centrations of ET-1 of 10 M. Likewise, the vasoconstriction seen was greater in the older rats (groups II and III) when compared to the young 3.
Effect of endothelin-1 on coronary flow following rats (group I).
inhibition of endogenous vasodilator release (Fig. 4) 
Comparison of effects of endothelin-1 pre vs. post
A dose-dependent decrease in coronary flow was seen in cardioplegic arrest (Fig. 3) response to ET-1 following the blockade of NO synthase and prostacyclin release. The vasoconstrictor response seen The effects of ET-1 were compared pre vs. post 4 h of in rats in groups I and II was similar. The increased cold ischaemia in the different age groups. There were no vasoconstriction seen in the older rats (group III) during significant differences in baseline coronary flows when perfusion with normal Krebs, when compared to rats in experiments performed prior to ischaemia were compared group I, was also seen during blockade of endogenous to post-ischaemic experiments (P5NS; for values, see vasodilator release. Table 1 ). Cardioplegic arrest decreased post-ischaemic coronary flow to 7966% of pre-ischaemic flow in group I, 75613% in group II and 8466% in group III (P5NS 3.5. Effect of sarafotoxin S6c on coronary flow at between groups). In the group I animals, there was a different ages (Fig. 5 ) 
Effect of sarafotoxin S6c on coronary flow
vasoconstrictor response in the adult and senescent rats.
following inhibition of endogenous vasodilator release
However, following inhibition of endogenous vasodilator (Fig. 6) release, perfusion with the ET agonist revealed a vas-B oconstrictor response in rats of all ages, with an increased Following the blockade of NO and prostacyclin release, response in the older rats. there was a significant vasoconstrictor response to S6c in Resting coronary tone depends on a variety of factors. rats of all ages, unlike in the experiments with plain Krebs This includes the balance between the endogenous release in which a significant response was only seen in the older of vasodilator (i.e. NO, prostacyclin) and vasoconstrictor animals (groups II and III). There was a trend towards an substances (i.e. ET) [23, 24] . We have previously demonincreased constrictor response with age. However, this was strated that both basal and stimulated release of NO by the only statistically significant between rats in groups I and coronary endothelium decreases with age in a rat model III (P,0.03). Likewise to experiments with plain Krebs, [8] . the constriction seen did not appear to be dose-dependent, There appears to be considerable heterogeneity in with similar responses to the different concentrations response to ET in different vascular beds. Some studies studied.
have shown a reduced response to ET-1 with age in the rat aorta, mesenteric and renal arteries [18] [19] [20] . However, it has also been reported that ET-1 has no effect with ageing 4. Discussion in rat aorta [21] . A study using rings of isolated rat coronary artery showed an increased response to ET with This study has shown that the coronary vasoconstrictor age [25] . To date, there are no studies looking at the effect of ET-1 increases with age. A similar finding was response to ET and S6c in the intact coronary circulation seen following 4 h of ischaemia at 48C. The amount of of the rat, or in other species. coronary vasoconstriction seen following ischaemia was
In this study, we have demonstrated that the coronary greater in rats of all ages. Following the inhibition of vasoconstriction seen in response to ET-1 is increased with endogenous vasodilator release, the effect of ET-1 was still advancing age. This result is in contrast to studies in other greatest in the senescent rats compared to the younger age vascular beds in which the effect of ET-1 is unaltered or groups. Perfusion with an ET agonist produced no effect reduced with ageing [18] [19] [20] [21] . This difference may be due B on coronary flow in the young rats, however, it produced a to increased ET receptor density, or increased receptor what role this increased sensitivity to ET may play in the did not increase significantly between the adult and adult circulation. senescent rats. It appears that the coronary circulation in Ischaemia and reperfusion result in a reduction in the rat becomes more sensitive to ET, particularly during coronary flow (so called 'low coronary reflow') [16] . It has been suggested that elevated levels of ET may be respontion for the increased vasoconstriction seen with ageing sible, at least in part, for the low coronary reflow phenommay be through a reduced ability to secrete NO in ageing enon [17] . ET-1 levels in plasma are raised with increasing coronary arteries [8] . This has been shown not to be the age [26, 27] . In this study, we have shown that there is an case in these studies. In the presence of L-NAME and enhanced response to ET-1 with age following prolonged indomethacin, there was still a significantly greater vascardioplegic arrest. In addition, the degree of vasoconstricoconstrictor response in the older animals. This would tion was greater for all age groups when compared to the suggest that the difference seen with ageing is due to experiments performed prior to ischaemia. This is in changes in ET receptor binding or density, and not due to keeping with the findings of other groups who have the previously observed reduction in endogenous vasodilatdemonstrated increased sensitivity to ET-1 following or release. periods of warm (378C) ischaemia [28, 29] . These findings
In this study, we have also shown that the response to may have implications for cardiac surgery and cardiac the ET agonist sarafotoxin S6c increases with ageing.
B transplantation, especially when older hearts undergo There was no response seen in the young rats in response surgery, or are being selected for potential donors. It is to S6c, whereas a significant vasoconstriction was seen in possible that older hearts may be more prone to low the adult and senescent animals. ET receptor stimulation B coronary reflow following prolonged periods of hypocan cause both vasoconstriction or vasodilatation [31] [32] [33] . thermic storage. There is some experimental evidence that It is possible that, in the younger animals, these effects inhibition of ET-1 during ischaemia may improve coronary cancelled each other out, whereas in the older animals, the flow following prolonged cardioplegic arrest [17] .
vasoconstrictor response predominated. Indeed, in the In mammalian tissue, ET-1 acts at two receptors (ET series of experiments where endogenous vasodilator re-A and ET ). The predominant receptor type is ET , which lease was blocked, S6c produced a constrictor response in B A mediates vasoconstriction of smooth muscle cells [30] . rats of all ages. Similarly to the experiments with ET-1, the ET receptors are present on both endothelial cells (where vasoconstrictor response to S6c increased with age. The B they mediate vasodilatation through the release of NO and observed response to S6c was less than that to ET-1. It prostacyclin) and smooth muscle cells (where they mediate appears therefore that the constrictor responses to both ET A vasoconstriction) [31, 32] . The result of this is that ET-1 and ET are altered with ageing.
B may partially regulate the amount of vasoconstriction it There are a number of limitations to this study. Firstly, a causes through a negative feedback loop via ET receptors crystalloid perfused isolated heart does not accurately B (producing NO and prostacyclin). One possible explanarepresent the normal conditions experienced by the heart in
